1
John W Erickson, Dominique P Bridon, Martin Robitaille, Grant A Krafft, Dong Xie, Elena Afonina, Jun Liang, Sandra DeMeyer: Long lasting fusion peptide inhibitors for HIV infection. Conjuchem Biotechnologies, Lando & Anastasi, June 22, 2010: US07741453 (9 worldwide citation)

The present invention relates to C34 peptide derivatives that are inhibitors of viral infection and/or exhibit antifusogenic properties. In particular, this invention relates to C34 derivatives having inhibiting activity against human immunodeficiency virus (HIV), respiratory syncytial virus (RSV), ...


2
John W Erickson, Dominique P Bridon, Martin Robitaille, Grant A Krafft, Dong Xie, Elena Afonina, Jun Liang, Sandra DeMeyer: Long lasting fusion peptide inhibitors for hiv infection. Morrison & Foerster, March 24, 2005: US20050065075-A1

The present invention relates to C34 peptide derivatives that are inhibitors of viral infection and/or exhibit antifusogenic properties. In particular, this invention relates to C34 derivatives having inhibiting activity against human immunodeficiency virus (HIV), respiratory syncytial virus (RSV), ...


3
Abelardo Silva, John E Erickson, Michael Eissenstat, Elena Afonina, Sergei Gulnik: Long Acting Biologically Active Conjugates. Sequoia Pharmaceuticals, Proskauer Rose, September 6, 2007: US20070207952-A1

The invention provides biologically active compounds that may be reacted with macromolecules, such as albumin, to form covalent linked complexes wherein the resulting complexes exhibit a desired biological activity in vivo. More specifically, the complexes are isolated complexes comprising a biologi ...


4
John W Erickson, Dominique P Bridon, Martin Robitaille, Grant A Krafft, Dong Xie, Elena Afonina, Jun Liang, Sandra De Meyer: Long lasting fusion peptide inhibitors for hiv infection. Conjuchem Biotechnologies, July 7, 2011: US20110166061-A1

The present invention is concerned with This invention relates to C34 peptide derivatives that are inhibitors of viral infection and/or exhibit antifusogenic properties. In particular, this invention relates to C34 derivatives having inhibiting activity against human immunodeficiency virus (HIV), re ...



Click the thumbnails below to visualize the patent trend.